In summary, we concluded that CERS1 plays a suppressor role in NSCLC BM by interacting with USP14 and downregulating the PI3K/AKT/mTOR signaling pathway, which may serve as a novel therapeutic target for NSCLC BM. This evidence concerns the gene USP14 and non-small cell lung carcinoma.